comprehensive -WSS

comprehensive

author：focus 2025-10-01 10:58:28 - browse：22315

The Food and Drug Administration is poised to tell drug and medical device makers how to better include people of color in the clinical trials that test whether products work and are safe, an agency official said Wednesday. Those guidelines are five months late.

To ensure that drugs work for everyone, they must be tested on a representative sample of people. But researchers have found that many clinical trials exclude the people of color who are often most affected by the diseases that drugs treat.

To help fix that problem, Congress passed a law requiring companies to give the FDA their plans for diversifying clinical trials. As part of that process, the agency was expected to issue guidance by the end of last year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Scientists uncover potential path to treating deadly childhood tumor

hotspot

WSS

Hundreds died while taking an arthritis drug, but nobody alerted patients

Pancreatic cancer is often deadly, but new discoveries are raising hope

Hundreds died while taking an arthritis drug, but nobody alerted patients

FDA approves Sage Therapeutics’ rapid

CDC recommends RSV monoclonal antibody for infants

CDC recommends RSV monoclonal antibody for infants

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Medical records are filled with copy

Scientists uncover potential path to treating deadly childhood tumor

Malaria cases in Florida and Texas: Here’s what you need to know

H.R. 3 is the wrong path to lower drug costs

Walensky prepares to leave CDC — and Congress — behind

Bird flu in dairy cattle: New measures to control spread to humans

Jerome Adams on the need for new antivirals for Covid

Physicians aren't 'burning out.' They're suffering from moral injury

DIEP, the 'gold standard' of breast reconstruction, is under threat

Covid silver lining: Unprecedented look at human immune system

Wikipedia

First Opinion on colorectal cancer screening: letter and response

How I helped Pfizer think through the ethics of Viagra

Young boy dies in trial for Pfizer Duchenne gene therapy

Scientific mystery highlights the blind spots in genomics databases

'Null' research findings aren't empty of meaning. Let's publish them

The a glaring gap in research on serious mental illness and primary care

hotspot

hotspot

focus

hotspot